» Articles » PMID: 18441153

The Satiety Hormone Peptide YY As a Regulator of Appetite

Overview
Journal J Clin Pathol
Specialty Pathology
Date 2008 Apr 29
PMID 18441153
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is a major cause of premature death in the UK, and may contribute to as many as 30 000 deaths a year in the UK. Although effective treatment for obesity is still awaited, many developments have occurred to improve our understanding of neuroendocrine regulation of food intake and weight gain, especially regarding the role of gut hormones. One such gut hormone is peptide tyrosine-tyrosine also known as PYY where Y depicts the abbreviation for tyrosine. PYY is a 36 amino acid hormone, first isolated from porcine intestine. PYY, along with few other gut hormones, has been suggested as a potential therapeutic agent for obesity. This review examines the relationship of PYY to appetite regulation, energy homeostasis and the relevant neuroendocrine feedback mechanism.

Citing Articles

The Gut-Brain Axis and Its Role in Controlling Eating Behavior in Intestinal Inflammation.

Moran G, Thapaliya G Nutrients. 2021; 13(3).

PMID: 33803651 PMC: 8003054. DOI: 10.3390/nu13030981.


Influence of Short-Term Hyperenergetic, High-Fat Feeding on Appetite, Appetite-Related Hormones, and Food Reward in Healthy Men.

Thackray A, Willis S, Clayton D, Broom D, Finlayson G, Goltz F Nutrients. 2020; 12(9).

PMID: 32872401 PMC: 7551053. DOI: 10.3390/nu12092635.


Impact of Nutrient Type and Sequence on Glucose Tolerance: Physiological Insights and Therapeutic Implications.

Nesti L, Mengozzi A, Trico D Front Endocrinol (Lausanne). 2019; 10:144.

PMID: 30906282 PMC: 6418004. DOI: 10.3389/fendo.2019.00144.


Proceedings of the 2017 ASPEN Research Workshop-Gastric Bypass: Role of the Gut.

Jain A, le Roux C, Puri P, Tavakkoli A, Gletsu-Miller N, Laferrere B JPEN J Parenter Enteral Nutr. 2018; 42(2):279-295.

PMID: 29443403 PMC: 5955776. DOI: 10.1002/jpen.1121.


Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options.

Isidro M, Cordido F Pharmaceuticals (Basel). 2016; 3(1):125-145.

PMID: 27713245 PMC: 3991023. DOI: 10.3390/ph3010125.